Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational study

Carlos K.H. Wong, Ivan C.H. Au, Kristy T.K. Lau, Eric H.Y. Lau, Benjamin J. Cowling, Gabriel M. Leung
doi: https://doi.org/10.1101/2022.05.19.22275291

Article usage

Article usage: May 2022 to September 2024

AbstractFullPdf
May 202295523294181
Jun 202230872141231
Jul 20223694166786
Aug 20222928193547
Sep 2022128944237
Oct 202283042160
Nov 202267156145
Dec 202250671165
Jan 202344542115
Feb 20232863063
Mar 20232562752
Apr 20232061838
May 20231672230
Jun 20231991425
Jul 2023110914
Aug 20231181827
Sep 20231481943
Oct 20231351422
Nov 2023962924
Dec 202384923
Jan 202477710
Feb 202487822
Mar 2024931125
Apr 20241021920
May 20241041125
Jun 2024143828
Jul 20241191427
Aug 2024841627
Sep 202456910
Back to top
Posted July 13, 2022.
Download PDF
Data/Code
Email
Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational study
Carlos K.H. Wong, Ivan C.H. Au, Kristy T.K. Lau, Eric H.Y. Lau, Benjamin J. Cowling, Gabriel M. Leung
medRxiv 2022.05.19.22275291; doi: https://doi.org/10.1101/2022.05.19.22275291
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area